Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. Revenue 2020–2023
Gain Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Gain Therapeutics Inc. revenue for the quarter ending March 31, 2023 was 55180, a 47.00% increase year-over-year.
- Gain Therapeutics Inc. revenue for the twelve months ending March 31, 2023 was 203791, a 103.88% increase year-over-year.
- Gain Therapeutics Inc. annual revenue for 2023 was 55180, a 58.40% decrease from 2022.
- Gain Therapeutics Inc. annual revenue for 2022 was 132640, a 0.96% decrease from 2021.
- Gain Therapeutics Inc. annual revenue for 2021 was 133928, a 363.72% increase from 2020.
- Gain Therapeutics Inc. annual revenue for 2020 was 28881.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Gain Therapeutics Inc. Earnings — FAQ
Gain Therapeutics Inc. (GANX) earnings over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GANX's earnings history?
The chart and table above show Gain Therapeutics Inc.'s earnings by year and by quarter, including the growth rate.